Home/Critical Appraisal
Critical Appraisal

Cohort Study

EM FINAL EXAMS Critical Appraisal · Study design Cohort Study Take groups defined by their exposure and follow them FORWARD in time to compare how often the outcome occurs. Definition An observational study that follows an exposed and an unexposed group forward, measures outcome incidence in each, and compares them — yielding a relative risk. […]

EM FINAL EXAMS Critical Appraisal · Study design

Cohort Study

Take groups defined by their exposure and follow them FORWARD in time to compare how often the outcome occurs.

Definition

An observational study that follows an exposed and an unexposed group forward, measures outcome incidence in each, and compares them — yielding a relative risk. It can be prospective (assemble now, follow forward) or retrospective (use existing records to look back at exposure, then forward to outcome).

The picture

Exposed vs unexposed, followed forward → compare outcome incidence → relative risk.

What it shows

Two groups separated only by exposure status at the start, tracked over time, with the rate of new outcomes in each compared at the end. Because exposure is recorded before the outcome appears, a cohort establishes temporality — the cause precedes the effect.

How to read it

Start at the left with people who do not yet have the outcome, split by whether they are exposed, then read rightward in time. Divide the outcome incidence in the exposed by that in the unexposed to get the relative risk: RR > 1 = exposure raises risk, RR < 1 = protective, RR = 1 = no association.

Why it matters

Cohorts are the natural design for prognosis and harm — where randomising the exposure would be unethical or impossible — and handle common and multiple outcomes well. But because allocation is not random, any difference may be driven by confounders rather than the exposure itself.

Key
  • Direction: exposure → outcome (forward in time)
  • Effect measure: relative risk (or rate ratio)
  • Best for: prognosis, harm, common & multiple outcomes
Pitfall
Pitfall Confounding — the exposed and unexposed groups differ by more than just the exposure (age, smoking, comorbidity), so the apparent effect may belong to the confounder, not the exposure. Adjustment helps only for confounders you have measured.
emfinalexams.com · FRCEM / MRCEM revision
EM trial in the wild

Framingham Heart Study (from 1948) — a prospective cohort that enrolled 5,209 outwardly healthy residents of Framingham, Massachusetts and followed them for decades. By comparing outcome incidence across exposure groups it established that smoking, hypertension and high cholesterol predict cardiovascular disease — it gave medicine the very phrase “risk factor”. No one could ethically randomise people to smoke for 30 years — this is exactly the kind of harm/prognosis question only a cohort can answer.

Examiner traps
  • Confounding — assuming an association is causal when an unmeasured factor differs between the groups.
  • Attrition / loss to follow-up — if dropouts are related to exposure or outcome it biases the result.
  • Healthy-worker effect — an “exposed” occupational group looks healthier simply because the sick never started or left the job.
Quick check

Why use a cohort study rather than an RCT to study harm?
Answer: Harmful exposures (smoking, a toxin, a suspected dangerous drug) usually cannot be ethically randomised, so a cohort follows people who are exposed in the real world and compares their outcomes with the unexposed.

Related cards

Ready to build your plan? EMF Premium gives you all 40,000+ questions, 20 mocks and 1,215 OSCE stations from £29/month — or a one-off 3- or 6-month pass.

Share
0
    0
    Your Cart
    Your cart is emptyReturn to Shop